CIK 0001479419 · Non-accelerated filer<br>Smaller reporting company
KALA BIO, Inc.
Sign in to watch- Ticker
- KALA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 270604595
- Phone
- 781-996-5252
- Business address
- 1167 MASSACHUSETTS AVENUE, ARLINGTON, MA, 02476
- Former names
- KALA BIO, Inc., Kala Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-31 | Iwicki Mark T CHIEF EXECUTIVE OFFICER | Returned to the company · Stock Option (right to buy) | −6,059 | 0 | ||
| 2023-05-31 | Iwicki Mark T CHIEF EXECUTIVE OFFICER | Returned to the company · Stock Option (right to buy) | −15,499 | 0 | ||
| 2023-05-31 | Iwicki Mark T CHIEF EXECUTIVE OFFICER | Returned to the company · Stock Option (right to buy) | −2,268 | 0 | ||
| 2023-03-14 | Kharabi Darius CHIEF BUSINESS OFFICER | Grant or award · Stock Option (Right to Buy) | +432 | 432 | ||
| 2023-03-14 | Trachtenberg Eric SEE REMARKS | Grant or award · Stock Option (Right to Buy) | +432 | 432 | ||
| 2023-03-14 | Reumuth Mary CHIEF FINANCIAL OFFICER | Grant or award · Stock Option (Right to Buy) | +432 | 432 | ||
| 2023-03-14 | Brazzell Romulus K SEE REMARKS | Grant or award · Stock Option (Right to Buy) | +576 | 576 | ||
| 2023-03-14 | Bazemore Todd SEE REMARKS | Grant or award · Stock Option (Right to Buy) | +576 | 576 | ||
| 2023-03-14 | Iwicki Mark T CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (Right to Buy) | +1,512 | 1,512 | ||
| 2023-03-10 | Blumenkranz Mark S. Director | Grant or award | +2,013 | 5,167 | ||
| 2023-03-10 | Blumenkranz Mark S. Director | Grant or award | +65,634 | 168,454 | ||
| 2023-03-10 | Blumenkranz Mark S. Director | Grant or award | +497 | 1,276 | ||
| 2023-03-10 | Kharabi Darius CHIEF BUSINESS OFFICER | Grant or award | +6,977 | 22,407 | ||
| 2023-02-15 | Blumenkranz Mark S. Director | Other disposition | −3 | 3,154 | ||
| 2023-02-15 | Blumenkranz Mark S. Director | Other disposition | −68 | 102,820 | ||
| 2023-02-15 | Blumenkranz Mark S. Director | Other disposition | −2 | 779 | ||
| 2023-01-04 | Kharabi Darius CHIEF BUSINESS OFFICER | Grant or award | +9,525 | 15,439 | ||
| 2023-01-04 | Trachtenberg Eric SEE REMARKS | Grant or award | +9,525 | 11,555 | ||
| 2023-01-04 | Trachtenberg Eric SEE REMARKS | Sale | −60 | $28.55 | $2K | 11,495 |
| 2023-01-04 | Reumuth Mary CHIEF FINANCIAL OFFICER | Grant or award | +9,525 | 11,943 |
Page 11 of 12 · 236 trades